PDC

New Potential Approach to Develop HIV Vaccine from Montreal Clinical Research Institute

Nov 29, 2019 | AIDS, HIV, PDC, Plasmacytoid Dendritic Cells

1.7 million are infected with the human immunodeficiency virus (HIV) each year worldwide. They are condemned to lifelong antiretroviral therapy (ART) or risk developing fatal aids. Only 22.3 million out of 37.9 million have access to ART, offering that group near...

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

159 WEST BROADWAY SUITE 200
SALT LAKE CITY, UT 84101

New Potential Approach to Develop HIV Vaccine from Montreal Clinical Research Institute

Pin It on Pinterest